Clinical trials
Macular Degeneration trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 6 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 13 |
| Recruiting | 9 |
| Not yet recruiting | 4 |
| Active, not recruiting | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Chengdu Kanghong Biotech Co., Ltd. | 3 |
| Shanghai Henlius Biotech | 3 |
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| AnewPharma | 2 |
| Beijing Tongren Hospital | 2 |
| Bio-Thera Solutions | 2 |
| Chengdu Origen Biotechnology Co., Ltd. | 2 |
| Innostellar Biotherapeutics Co.,Ltd | 2 |
| Peking University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 48 |
| Choroidal Neovascularization | 5 |
| Geographic Atrophy | 5 |
| Diabetic Retinopathy | 4 |
| Retinal Vein Occlusion | 4 |
| Vision Disorders | 4 |
| Wet Macular Degeneration | 3 |
| Myopia, Degenerative | 2 |
| Polypoidal Choroidal Vasculopathy | 2 |
| Retinal Diseases | 2 |
Trials
Showing 26 to 48 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.